Arca
Skip to content
Tools
Tools

Refractory anemia

Drug research and approvals for refractory anemia: what is recruiting, what Health Canada authorized, FDA orphan designations and EU medicines. See every condition.

As of Nov 21, 2026, 60 studies of refractory anemia are recruiting on ClinicalTrials.gov, Health Canada has authorized 0 drug trials for it since 2013, and FDA has 2 approved and 0 open orphan designations naming it.

  • Recruiting worldwide: 60
  • Trials authorized in Canada: 0
  • FDA orphan approvals: 2
  • EU medicines: 0

Recruiting now

Newest posted first, of 60 recruiting on ClinicalTrials.gov ↗

Drug pipeline

Each drug at the furthest stage it has reached for this condition, from ChEMBL's drug indications

Phase 3 11

Phase 2 1

How its trials ended

65 ClinicalTrials.gov studies of the condition, classified by TrialPanorama, partly automatically, so some labels are wrong

Of the 21 whose ending is known, 48% met their primary endpoint, 10% missed it and 43% stopped early.

  • Completed, result not reported3655%
  • Met its primary endpoint1015%
  • Ongoing58%
  • Stopped: funding58%
  • Status unknown35%
  • Missed its primary endpoint23%
  • Stopped: other or unclear23%
  • Stopped: safety12%
  • Stopped: sponsor or business decision12%

FDA orphan designations

Approved first, then open designations, newest first
May 2, 2006DacogenFor treatment of patients with myelodysplastic syndromes (MDS) including previously treated and untreated, de novo and secondary MDS of all…Otsuka Pharmaceutical DevelopmentApproved
May 19, 2004VidazaTreatment of patients with the following myelodysplastic syndrome subtypes: refractory anemia or refractory anemia with ringed sideroblasts…Celgene CorporationApproved

Condition names come from Health Canada's trial database. Orphan designations and EU medicines are matched when their indication names the condition as whole words, so a broader or differently worded indication can be missed. Recruiting counts are live from ClinicalTrials.gov's own condition search, refreshed daily. ClinicalTrials.gov, Health Canada Clinical Trials Database, FDA orphan designations, EMA

Esc

Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.